相关实验视频
Updated: Jan 20, 2026

09:09
In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
2.2K
水,卫生和卫生干预对临床瘤的影响:一个集群随机试验
Dionna M Wittberg1, Fisseha Admassu2, Solomon Aragie3
1Francis I Proctor Foundation, University of California, San Francisco, California, USA.
Tropical medicine & international health : TM & IH
|January 18, 2026
概括
综合性水,环境卫生和卫生 (WASH) 干预措施没有减少埃塞俄比亚一个高度流行地区的临床气管瘤. 这项研究强调了对有效的气管瘤消除策略的进一步研究的需要.
科学领域:
- 眼科医生 眼科 眼科
- 传染性疾病 传染性疾病
- 公共卫生 公共卫生
背景情况:
- 在全球范围内,气管瘤仍然是可预防失明的主要原因.
- 卫生干预对于瘤消除策略至关重要,但随机试验的证据有限.
- 这项研究解决了了解综合水,环境卫生和卫生 (WASH) 干预措施对气管瘤的影响的差距.
研究的目的:
- 评估综合性WASH干预措施在减少气管瘤临床症状方面的有效性.
- 评估WASH干预措施在埃塞俄比亚一个高度流行地区的影响.
- 为全球气管瘤消除战略提供证据.
主要方法:
- 一个平行组集群随机试验,涉及40个埃塞俄比亚社区.
- 社区被随机分为1:1进行WASH干预或延迟干预 (控制).
- 临床气管瘤每年通过0-9岁儿童的结膜摄影进行评估,没有大规模的抗生素给药.
主要成果:
- 3年后,在WASH组和对照组之间,毛囊或乳头细胞平均数量没有显著差异.
- 平均毛囊分数在两组中都增加,而在WASH手臂中,较高分数的趋势并不显著.
- 在这两只手臂中都没有报告任何不良事件,这表明干预的安全性.
结论:
- 在没有大规模的抗生素分发的情况下,综合的WASH干预措施并没有降低在超级endemic环境中的临床气管瘤结局.
- 这些发现表明,单独的WASH干预可能不足以消除这些地区的气管瘤.
- 需要进一步的研究来探索有效控制气管瘤的联合策略.
相关概念视频
Clinical Trials
10.2K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.2K
Clinical Trials: Overview
4.6K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.6K
09:09In Silico Clinical Trials for Cardiovascular Disease
2.2K
This protocol demonstrates the workflow of the SILICOFCM platform for automatically generating a parametric model of the left ventricle from patient-specific ultrasound images by applying a multi-scale electromechanical model of the heart. This platform enables in silico clinical trials intended to reduce real clinical trials and maximize positive therapeutic...
2.2K
Statistical Software for Data Analysis and Clinical Trials
1.4K
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.4K
14:45Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay
15.5K
In this report, we demonstrate the staining and analysis steps of a phenotyping assay performed on fresh whole blood to enumerate major innate and adaptive leukocyte populations. We emphasize considerations for performing these procedures in the context of a multicenter clinical...
15.5K
05:16Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides
7.3K
Here, we present the molecular characterization of dystrophin 38 expression using Sanger sequencing, RT-PCR, and western blotting in the clinical...
7.3K